Doctor’s Passport

Find your next topic

Explore the current textbook

Available drafts · Clinical review pending
Membership
Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
Rapid

CT angiography and catheter angiography

Essential points for quick revision.

Saved on this device
!
Confirmed subarachnoid haemorrhage needs vascular definition

A negative or equivocal angiogram does not make a convincing aneurysmal blood pattern safe, and discovery of an aneurysm does not prove that it is the ruptured lesion unless the anatomy and blood distribution agree.

Action: Discuss confirmed subarachnoid haemorrhage urgently with a specialist neurosurgical centre, obtain CTA without delay, and escalate discordant or negative studies to interventional neuroradiology and neurosurgery while rebleeding precautions continue.

Synopsis

Choose and interpret CT angiography and catheter digital subtraction angiography after intracranial haemorrhage, recognising technical limits and acting when vascular anatomy does not explain the bleeding pattern.

  • Non-contrast CT establishes the presence and distribution of acute blood; vascular imaging answers a different question: what vessel lesion caused it and how can it be treated?
  • NICE NG228 says to offer head CTA without delay after confirmed subarachnoid haemorrhage to identify the cause and guide treatment.
  • An aneurysm is the likely culprit only when it fits the blood pattern; if CTA is negative but suspicion remains, consider catheter DSA, or MRA when DSA is contraindicated.

Key red flags

A basal cisternal or focal arterial-territory pattern of subarachnoid blood with negative CTA retains a possible occult aneurysm and merits specialist consideration of DSA.

An aneurysm remote from the haemorrhage distribution may be incidental; securing the wrong lesion leaves the true rupture source untreated.

Falling consciousness, a new focal deficit, seizure or worsening headache during angiographic work-up may indicate rebleeding, hydrocephalus or ischaemia and requires immediate clinical reassessment and non-contrast CT.

Contrast allergy, renal impairment, pregnancy, anticoagulation and difficult arterial access alter risk and planning but do not justify abandoning time-critical vascular diagnosis without specialist alternatives.

Catheter angiography carries arterial injury, thromboembolism, access-site bleeding and contrast risks; new neurology during or after the procedure is an emergency.

Possible incidental aneurysm

A lesion whose side and arterial location do not fit the clot distribution may be non-culprit; an interventional neuroradiologist and neurosurgeon should review the mismatch without delay.

Occult vascular lesion

A negative CTA despite convincing aneurysmal SAH may reflect a very small, thrombosed or technically obscured aneurysm and is the key situation in which NICE advises considering DSA.

Procedure complication

New focal deficit, severe headache, reduced consciousness, limb ischaemia or expanding access-site swelling after DSA requires immediate assessment for embolus, dissection, rebleeding or access haemorrhage.

Investigation priorities

01
CT angiography of the headFirst step

Rapidly identify an aneurysm or other arterial cause and define anatomy for immediate specialist planning.

02
Catheter digital subtraction angiographyPreferred

Provide the preferred specialist selective dynamic anatomy when aneurysm suspicion persists after negative or equivocal CTA.

Management branches

Acute imaging pathwayConfirmed subarachnoid haemorrhage

Non-contrast CT or CSF analysis has confirmed subarachnoid haemorrhage and a vascular cause must be defined.

  1. Discuss urgently with the specialist neurosurgical centre and review the non-contrast blood distribution, neurological state, renal function, allergy history and any previous aneurysm treatment.
  2. Offer CTA without delay and compare every lesion with the blood pattern; if CTA is negative but aneurysm suspicion persists, consider catheter DSA, or MRA when DSA is contraindicated.
Open full textbook Answer 2 questions
Sources and review status3 sources · checked 13 Sept 2026 · clinical review pending
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Apply principles in context and verify current guidance when a decision affects care. Source check completed 13 Sept 2026; clinical approval remains outstanding.

  • NICE NG228 aneurysmal subarachnoid haemorrhage recommendationsNICE guideline NG228, published 23 November 2022; recommendations and rationale sections 1.1.16–1.3.6 read 13 September 2026. Applies to people with confirmed or suspected aneurysmal subarachnoid haemorrhage in England; UK nations decide applicability separately. Chapter-specific use: vascular source detection and angiographic limits.
  • 2026 ESO–EANS–ESMINT aneurysmal subarachnoid haemorrhage guidelineJoint European professional guideline published 7 May 2026; PICO 3a–3b on coiling, clipping and adjunctive endovascular devices, PICO 4 on DCI prevention, PICO 5a–5b on DCI rescue, PICO 6 on monitoring and PICO 7 on hydrocephalus read 13 September 2026. Evidence population is predominantly adults with acute saccular aSAH; NICE remains the UK practice anchor. Chapter-specific use: vascular source detection and angiographic limits.
  • NICE NG228 evidence review K: diagnostic imaging strategiesFinal NICE evidence review K, November 2022; diagnostic accuracy, modality characteristics and committee discussion for CTA, DSA and MRA read 13 September 2026. Evidence applies to suspected aneurysmal causes of confirmed SAH, not screening incidental aneurysms in the general population.
Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom